Address correspondence to Dr Wolfgang Singer, Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, firstname.lastname@example.org.
RELATIONSHIP DISCLOSURE: Dr Coon reports no disclosure. Dr Singer serves on the editorial board of Autonomic Neuroscience: Basic & Clinical, as an associate editor for Clinical Autonomic Research, as a consultant for Biohaven Pharmaceuticals, and on an advisory board for Lundbeck. Dr Singer receives research/grant support from Dysautonomia International, the US Food and Drug Administration (R01 FD4789), and the National Institutes of Health (R01 NS092625, U54 NS65736).
UNLABELED USE OF PRODUCTS/INVESTIGATIONAL USE DISCLOSURE: Drs Coon and Singer discuss the unlabeled/investigational use of pyridostigmine for orthostatic hypotension and clonazepam and melatonin for dream enactment behavior.